What does Zambon do?
ZAMBON is a pharmaceutical company that specializes in developing and manufacturing a wide range of healthcare products. The company focuses on innovative solutions in the fields of respiratory, pain management, and infectious diseases. ZAMBON is committed to improving patient outcomes through research and development of high-quality medicines.
- Sectors
- Wholesalers
- Signals
-
ProfitableProfitable € 1.45M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.96MStrong equity provides a buffer against setbacks.
Low riskLow risk 38.5%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.62A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.48MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.95MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 18.82MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 20.5%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
18.82M
|
€
19.07M
|
€
18.93M
|
€
17.39M
|
|
|
€
1.95M
|
€
1.76M
|
€
1.07M
|
€
30K
|
|
|
€
1.45M
|
€
1.45M
|
€
787K
|
€
101K
|
|
|
€
2.96M
|
€
2.88M
|
€
2.94M
|
€
2.95M
|
|
|
38.52%
|
37.41%
|
39.60%
|
44.21%
|
|
|
€
4.72M
|
€
4.82M
|
€
4.49M
|
€
3.72M
|
|
|
Cash
|
|
|
|
€
1K
|
|
20.40
|
22.60
|
22.60
|
25.50
|
Publications 74
All publications- Ontslagen - Benoemingen 03/03/2026
- Ontslagen - Benoemingen 24/01/2025
- Ontslagen - Benoemingen 12/08/2022
- Ontslagen - Benoemingen 24/06/2022
- Kapitaal - Aandelen 09/06/2022
Frequently asked questions
Answers to the most common questions about Zambon, based on official government data and the filed annual accounts.
What is the VAT number of Zambon?
The VAT number of Zambon is BE0403.069.741.
How many employees work at Zambon?
In 2025, Zambon employed 20.40 full-time equivalents (FTE).
When was Zambon established?
Zambon was founded in 19-07-1965.
What is the official address of Zambon?
The official address of Zambon is Burgemeester Etienne Demunterl. 3 Jette 1090.
What is the legal form of Zambon?
The juridical form of Zambon is Public limited company (NV/SA).
What is the annual revenue of Zambon?
The revenue of Zambon for the 2025 financial year was €18,820,434.
What does Zambon do?
ZAMBON is a pharmaceutical company that specializes in developing and manufacturing a wide range of healthcare products. The company focuses on innovative solutions in the fields of respiratory, pain management, and infectious diseases. ZAMBON is committed to improving patient outcomes through research and development of high-quality medicines.
Is Zambon a reliable company?
Zambon is a registered Rechtspersoon with company number 0403.069.741 and can be verified through the official CBE database.
What is the credit limit of Zambon?
The estimated credit limit of Zambon is €3,393,177.
Is Zambon still active?
Zambon currently has the status "Normal situation" and is active.